A simple tool has been developed to predict the delayed neurotoxicity that occurs in about half of patients who undergo CAR T-cell therapy. The score – based on readily available clinical and laboratory measures – will allow observation and treatment to be targeted at those most at risk, allowing low risk patients to be discharged ...
Tool predicts neurotoxicity with CAR T-cell therapy
By Michael Woodhead
12 Aug 2020